Press Release

CardioComm Solutions’ HeartCheck™ ECG PEN and GEMS™ Home Receive China Food and Drug Administration Clearance

by

Clearance opens the way for HeartCheck™ Device Sales and SMART Monitoring ECG Services in China TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, confirms that China’s Food and Drug Administration (“CFDA”) has cleared the HeartCheck™ PEN ECG device … Read more

CardioComm Solutions Establishes Research Partnership with University of Texas at Austin for HeartCheck™ ECG Services in Clinical Neuroendocrinology

by

HeartCheck™ Technologies to be used to identify people at risk for potentially life-threatening drug side effects TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced it has entered into a partnership agreement with the Clinical Neuroendocrinology Laboratory … Read more

CardioComm Solutions Executes Distribution and Co-Marketing Agreement to Promote HeartCheck™ PEN Sales and SMART Monitoring Services

by

SMART Monitoring Integration of Reka ECG monitoring device to provide access to new US-based and Global ECG Service Markets TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”)today announced that it has completed a HeartCheck™ and SMART Monitoring distribution and co-marketing agreement (“Agreement”) with Reka Health, Inc. (REKA), a US based … Read more

CardioComm Solutions Completes Technology Pilot in the Long-Term Patient Care Market with the HeartCheck™ ECG Monitor and SMART Monitoring ECG Service Technologies

by

Arrhythmia Surveillance Utilized HeartCheck™ Device and SMART Monitoring ECG Service Technologies TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”)today announced that it is working within a pilot that uses HeartCheck™ ECG testing technology to support arrhythmia screening and surveillance with long-term care facilities. The pilot was coordinated by Toronto-based In … Read more

FDA Clears CardioComm Solutions’ GUAVA II ECG Viewer with ECG Acquisition, Analysis, Interpretation, and Reporting Capabilities as a Class II Medical Device

by

GUAVA II offers regulatory credibility and efficiency to ECG reading services for physicians and hospitals TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, confirms U.S. Food and Drug Administration (“FDA”) clearance of its GUAVA II ECG viewer technology … Read more

CardioComm Solutions Announces Equity Financing

by

Funding will be used as bridge financing to complete Q1 2014 objectives. TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it will be conducting a non-brokered private placement equity financing under which it intends to issue between 4,166,667 to 8,333,334 units at a price of $0.12 per … Read more

CardioComm Solutions’ HeartCheckTM PEN ECG to be used in Clinical Monitoring for Arrhythmia Risk Screening and QT interval Prolongation

by

ECG monitoring to be performed by Sunnybrook Hospital (Toronto) through in-home SMART Monitoring services. Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced it is working with clinicians at Sunnybrook Hospital in Toronto to use the HeartCheckTM PEN handheld … Read more

CardioComm Solutions’ GEMS Home & SMART Monitoring Technologies Expanded To Support Prescription, HeartCheck™ Handheld ECG Devices

by

Rapid physician ECG interpretation services now available to patients, allied health care workers and physician groups. TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm Solutions” or the “Company”) today confirmed it has released a new version of its GEMS Home software to support the prescription model of the HeartCheck™ ECG Monitor. GEMS Home … Read more

CARDIOCOMM SOLUTIONS COMPLETES MOBILE CARDIAC TELEMETRY SOFTWARE RELEASE FOR RAYTEL CARDIAC SERVICES

by

Raytel Cardiac Services will be the first to launch into the American MCT monitoring market using the CardioComm Solutions Wireless Arrhythmia Services Software Toronto, Canada. – CardioComm Solutions Inc. ( TSX-V:EKG) (“CardioComm Solutions” or the “Company”) confirms the release of a custom GEMSTM Mobile Cardiac Telemetry software (“GEMS M-Air”) solution with web-based device interfacing for … Read more

CardioComm Solutions’ HeartCheck™ Technologies to be used in Canadian Parkinson’s Research Study.

by

Second CIHR and industry sponsored study to use HeartCheck and SMART Monitoring Technologies. Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced it shall be providing HeartCheckTM  based ECG screening technologies to researchers from the Research Institute of the … Read more